This website uses cookies
This website uses cookies. For further information on how we use cookies you can read our Privacy and Cookie notice
This website uses cookies. For further information on how we use cookies you can read our Privacy and Cookie notice
In stock
Free return within 7 days for ALL eligible itemsDetails
Cit
92%Seller Score
15 Followers
Shipping speed: Excellent
Quality Score: Excellent
Customer Rating: Good
ALOREPAIR is a topical solution for the treatment of alopecia adrogenetica (male pattern baldness of the vertex of the scalp and in females as diffuse hair loss or thinning of the frontoparietal areas). It promotes hair growth and the epithelium of hair bursa. The response is better when the patients use ALOREPAIR directly after hair loss. At least four months of twice-daily applications are generally required before evidence of hair growth can be expected. If a patient responds to treatment, he will need to continue using ALOREPAIR to maintain hair growth. In the treatment of alopecia androgenetica (male-pattern baldness) 1ml of a 2% or 5% solution of ALOREPAIR is applied twice daily to the scalp. The 5% solution is not recommended for women.
ALOREPAIR is a topical solution for the treatment of alopecia adrogenetica (male pattern baldness of the vertex of the scalp and in females as diffuse hair loss or thinning of the frontoparietal areas). It promotes hair growth and the epithelium of hair bursa. The response is better when the patients use ALOREPAIR directly after hair loss. At least four months of twice-daily applications are generally required before evidence of hair growth can be expected. If a patient responds to treatment, he will need to continue using ALOREPAIR to maintain hair growth. In the treatment of alopecia androgenetica (male-pattern baldness) 1ml of a 2% or 5% solution of ALOREPAIR is applied twice daily to the scalp. The 5% solution is not recommended for women.
Clinically proven to help regrow hair & treat hair loss
3 verified ratings
Customers who have bought this product have not yet posted comments